• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Regulation of Pharmaceuticals:: Balancing the Benefits and Risks

Regulation of Pharmaceuticals:: Balancing the Benefits and Risks

Paperback

Series: Decade of the Brain, Book 377

General LawGeneral Political Science

Publisher Price: $12.00

ISBN10: 0844735175
ISBN13: 9780844735177
Publisher: AEI Press
Published: Jan 1 1983
Pages: 80
Weight: 0.27
Height: 0.17 Width: 6.00 Depth: 9.00
Language: English

This is a must-read analysis for anyone navigating the ongoing debate over drug regulation, where economists John Vernon and Henry Grabowski dig into decades of empirical evidence on the FDA's impact on pharmaceutical innovation, drug approval delays, and industry profitability, tracing the effects of the 1962 Kefauver-Harris amendments to build a data-driven case for regulatory reform that remains essential reading for policymakers, healthcare professionals, and anyone concerned with the true costs of drug regulation.

Also in

General Law